Arrowhead Pharmaceuticals, Inc. (ARWR)
68.14
+1.67
(+2.51%)
USD |
NASDAQ |
Dec 19, 16:00
68.14
0.00 (0.00%)
After-Hours: 18:33
Arrowhead Pharmaceuticals Shareholders Equity (Annual): 466.05M for Sept. 30, 2025
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Sarepta Therapeutics, Inc. | 1.528B |
| Ionis Pharmaceuticals, Inc. | 588.35M |
| Alnylam Pharmaceuticals, Inc. | 67.09M |
| Amgen, Inc. | 5.877B |
| Pfizer Inc. | 88.20B |